ELOVL5 and breast cancer: The loss of Elovl5 expression did not trigger cell death (Supplementary Fig. S2B) but induced a cell cycle arrest in G0-G1 phase (Supplementary Fig. S2C) supporting the inhibition of proliferation in Elovl5-depleted breast cancer cells.